25–26 janvier 2008
Toulouse, France
Plus d’informations à venir
Liste des communications
Christopher P. Adams, « Spending on New Drug Development », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Emmanuelle Auriol, « Government Outsourcing: Public Contracting with Private Monopoly », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Lieke Boonen, « Which Preferred Providers are really Preferred? Evidence of a Discrete Choice Experiment », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Andrew Ching, « The Effects of Detailing on Prescribing Decisions under Two-Sided Learning », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Paris Cleanthous, « Innovate or Imitate? Strategic Innovation Decision in the Pharmaceutical Industry », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Matthias Dahm, « The Economics of Investment in Clinical Trials », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Patricia Danzon, « Effects of Regulation on Drug Launch and Pricing in Interdependent Markets », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Claudia Desogus, « Strategic Pricing and Antitrust Issues in the European Pharmaceutical Market: the Glaxo Case », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Juan-Jose Ganuza, « R&D in the Pharmaceutical Industry: A World of Small Innovations », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Alessandro Gavazza, « Dynamic Inefficiencies in Employment-Based Health Insurance: Theory and Evidence », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Catarina Goulão, « Voluntary Social Insurance », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Simona Grassi, « Subsidy Design and Asymmetric Information: Wealth versus Benefits? », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Izabela Jelovac, « External Referencing and Pharmaceutical Price Negoatiation », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Natalia Jorgensen, « The Effect of Double Insurance Coverage on Prevention », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Xavier Martinez-Giralt, « On International Cost-Sharing of Pharmaceutical R&D », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Frank Müller-Langer, « Parallel Trade and the Pricing of Pharmaceutical Products », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Carmine Ornaghi, « Mergers and Innovation in Big Pharma », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Niklas Potrafke, « Public Health Expenditures in OECD Countries: Does Policy Matter? », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.
Fiona Scott Morton, « The Effect of Medicare Part D on Pharmaceutical Prices and Utilization », The Economics of the Health Care and the Pharmaceutical Industry, Toulouse, France, 25–26 janvier 2008.